Alpha Tau Medical (DRTS) Operating Expenses (2021 - 2026)

Alpha Tau Medical has disclosed Operating Expenses across 6 years of filings, most recently posting $13.1 million for Q1 2026.

• Operating Expenses for Q1 2026 came in at $13.1 million, up 47.72% year-over-year; the trailing twelve-month figure through Mar 2026 was $44.7 million (up 28.86% YoY), and the FY2025 annual result was -$5.0 million, down 3.02% from the prior year.
• Operating Expenses came in at $13.1 million for Q1 2026 at Alpha Tau Medical, up from $12.1 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $13.1 million in Q1 2026 to a low of $7.1 million in Q3 2022.
• The 5-year median for Operating Expenses is $8.5 million (2024), against an average of $8.9 million.
• Across the five-year window, Operating Expenses soared 233.84% in 2022 and fell 7.31% in 2024, its largest moves.
• Alpha Tau Medical's Operating Expenses stood at $7.6 million in 2022, then advanced by 25.08% to $9.5 million in 2023, then advanced by 1.01% to $9.6 million in 2024, then advanced by 26.73% to $12.1 million in 2025, then increased by 7.59% to $13.1 million in 2026.
• The last three Operating Expenses figures came in at $13.1 million (Q1 2026), $12.1 million (Q4 2025), and $10.2 million (Q3 2025), per Business Quant data.